Status:

COMPLETED

Evaluation of Lung Function and Symptoms in Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD) on Long-Acting Bronchodilator Monotherapy

Lead Sponsor:

GlaxoSmithKline

Conditions:

Pulmonary Disease, Chronic Obstructive

Eligibility:

All Genders

40+ years

Brief Summary

A multicenter study to evaluate lung function and symptoms in subjects with COPD who have been on regular use of only one long-acting bronchodilator.

Eligibility Criteria

Inclusion

  • Cigarette smoking history-Current or ex-smokers (defined as stopped smoking for at least three months prior to the study visit)
  • Established history of COPD as diagnosed by a physician
  • Regular use (prescribed for use every day) of only one long-acting bronchodilator greater than or equal to one month before the study visit
  • Ability to read, comprehend, and record information in the English language

Exclusion

  • Currently active asthma (receiving asthma therapy and or having asthma symptoms)
  • Use of ipratropium/albuterol combination products greater than three times per day, use of inhaled corticosteroids, use of inhaled corticosteroid/long-acting beta-agonist combinations, theophylline preparations, or oral beta agonists within 3 months prior to the study visit
  • Previous lung surgery
  • Other respiratory disorders other than COPD
  • Current alcohol, illegal drug, or solvent abuse
  • Females with a positive urine pregnancy test at the study visit

Key Trial Info

Start Date :

December 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 1 2009

Estimated Enrollment :

1084 Patients enrolled

Trial Details

Trial ID

NCT00791518

Start Date

December 1 2008

End Date

May 1 2009

Last Update

July 30 2014

Active Locations (57)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 15 (57 locations)

1

GSK Investigational Site

Birmingham, Alabama, United States, 25249

2

GSK Investigational Site

Tucson, Arizona, United States, 85741

3

GSK Investigational Site

Little Rock, Arkansas, United States, 72205

4

GSK Investigational Site

National City, California, United States, 91950